Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy

NCT07091370 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

AIHA - Cold Autoimmune Hemolytic Anemia

Interventions

DRUG: Inaticabtagene Autoleucel Injection

Sponsor

Juventas Cell Therapy Ltd.